Home > Insider Trading > Stemline Therapeutics Inc

Stemline Therapeutics Inc (STML)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Stemline Therapeutics Inc (STML): Hedge Funds Are Snapping Up

Is Stemline Therapeutics Inc (NASDAQ:STML) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top ...

Keep Reading →

December 10th, 2019 - Hedge Funds News

Stemline Therapeutics Inc (STML) Is Burning These Hedge Funds

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...

Keep Reading →

October 30th, 2019 - Hedge Funds News

Hedge Funds Have Never Been This Bullish On Stemline Therapeutics Inc (STML)

Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would...

Keep Reading →

June 19th, 2019 - Hedge Funds News

13G Filing: Adage Capital Management and Stemline Therapeutics Inc (STML)

Adage Capital Partners GP, L.L.C., a limited liability company organized under the laws of the State of Delaware ("ACPGP"), as general partner of ACP with respect to the shares of Common Stock directly...

Keep Reading →

November 10th, 2017 - Hedge Funds

Stemline Therapeutics Inc (STML): What's The Other Side Of The Story?

Stemline Therapeutics Inc (NASDAQ:STML) is one of the biggest stories in the biotechnology space this week.

Keep Reading →

February 3rd, 2017 - News Stock Analysis

Biotech Movers: EnteroMedics Inc (ETRM) And Stemline Therapeutics Inc (STML)

We’re off to a big start for the fresh week in the biotech space, as the lull in volume that generally comes on the back of the holiday period has subsided, and both the institutional and the retail...

Keep Reading →

January 9th, 2017 - Market Movers News Stock Analysis

Is Stemline Therapeutics Inc (STML) a Good Stock to Buy?

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...

Keep Reading →

December 13th, 2016 - Hedge Funds News

Here’s Why These Five Stocks Are in Spotlight

U.S. stocks are trading higher ahead of manufacturing data along with new home sales data which is expected tomorrow.

Keep Reading →

August 23rd, 2016 - Commodities Market Movers News Tech

JUNO Therapeutics Inc (JUNO); Coherus Biosciences Inc (CHRS), Stemline Therapeutics Inc (STML): VCHP's Bullish Sentiment Pays Off

Juno Therapeutics Inc (NASDAQ:JUNO) is up by 15% as of Thursday afternoon, following the release of its first-ever earnings report since its IPO.

Keep Reading →

March 19th, 2015 - Hedge Funds News

Second Wave of Moves from SAC Capital

In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes to their equity portfolio.

Keep Reading →

April 4th, 2014 - Hedge Funds News